Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MIRTAZAPINE Cause Intentional product use issue? 64 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Intentional product use issue have been filed in association with MIRTAZAPINE (Mirtazapine). This represents 0.2% of all adverse event reports for MIRTAZAPINE.

64
Reports of Intentional product use issue with MIRTAZAPINE
0.2%
of all MIRTAZAPINE reports
14
Deaths
29
Hospitalizations

How Dangerous Is Intentional product use issue From MIRTAZAPINE?

Of the 64 reports, 14 (21.9%) resulted in death, 29 (45.3%) required hospitalization, and 9 (14.1%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MIRTAZAPINE. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does MIRTAZAPINE Cause?

Toxicity to various agents (2,758) Drug ineffective (1,874) Somnolence (1,695) Completed suicide (1,535) Fall (1,461) Intentional overdose (1,458) Drug abuse (1,408) Dizziness (1,234) Fatigue (1,192) Nausea (1,142)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which MIRTAZAPINE Alternatives Have Lower Intentional product use issue Risk?

MIRTAZAPINE vs MIRVASO MIRTAZAPINE vs MIRVETUXIMAB SORAVTANSINE-GYNX MIRTAZAPINE vs MISOPROSTOL MIRTAZAPINE vs MITAPIVAT MIRTAZAPINE vs MITOMYCIN

Related Pages

MIRTAZAPINE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue MIRTAZAPINE Demographics